Project HOPE is welcoming Richard T. Clark, Chairman of Merck & Co. Inc., as its new Chairman, deploying his decades of corporate leadership expertise as HOPE expands its global battle against disease and poor health.
“Dick Clark has played a leading role in shaping Project HOPE’s vision for the future – a vision to build HOPE’s capacity to address health crises that are threatening the future prosperity and development of societies worldwide,” said John P. Howe III, M.D., President and CEO of Project HOPE, a global health education and humanitarian assistance organization.
Mr. Clark brings four decades of leadership to the Board, where he has served as Acting Chairman since 2010. The expertise acquired during Mr. Clark’s tenure as CEO and Chairman of Merck, and his past executive and management experience at Merck in strategy, global manufacturing production, new products planning and engineering and as chairman, president and CEO of Medco Health Solutions, will help shape HOPE’s work in helping nations move from disaster to development, and sharing knowledge and skills to foster healthier communities in needy countries.
Mr. Clark succeeds Charles A. Sanders, M.D., who served as a member of the Project HOPE Board of Directors for 21 years and as its Chairman for 18 – the longest tenure in the organization’s 53-year history. Dr. Sanders was named HOPE’s Chairman Emeritus.
In addition to the transition of Board chairmen, George B. Abercrombie, retired President and CEO of pharmaceutical company Hoffman-LaRoche, was named HOPE’s new Vice Chairman. Mr. Abercrombie joined the HOPE Board in 2007. William F. Brandt, retired Chairman and CEO of American Woodmark, and Dayton Ogden, Chairman of SpencerStuart Worldwide, retained their titles as Board Treasurer and Secretary, respectively.
Project HOPE has been a beacon of global humanitarian medical care for more than 53 years, and earlier this year announced the HOPE In The Face of Crisis Campaign, which aims to raise $94 million by 2015. The funds will be used to expand HOPE’s operations, reducing death from preventable diseases, and building health infrastructure in countries limited by resources and devastated by natural disasters.
“It’s an honor be part of an organization like Project HOPE – a pioneer in the growing battle against global chronic disease and one that has a sterling reputation for building health systems in countries eager to improve the lives of their citizens through health and medical education,” said Mr. Clark.
Mr. Clark will retire Dec. 1 from his duties as Chairman of Merck, which is known as MSD outside the United States and Canada. Merck operates in more than 140 countries to deliver innovative health solutions through prescription medicines, vaccines, biologic therapies, and consumer care and animal health products.
Mr. Clark has served as Board Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country's leading pharmaceutical research and biotechnology companies. He is also a member of the Board of Trustees of PENN Medicine, an enterprise consisting of the University of Pennsylvania School of Medicine and the University of Pennsylvania Health System, which is dedicated to medical education, biomedical research and excellence in patient care. Additionally, Mr. Clark serves on the American Securities Advisory Board, Automatic Data Processing, Inc. (ADP) Board of Directors, and the Washington & Jefferson College Board of Trustees.
Mr. Clark earned his bachelor’s degree in liberal arts from Washington & Jefferson College, and his M.B.A. from American University. He served as a lieutenant in the U.S. Army from 1970 to 1972 before joining Merck.
About Project HOPE
Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is dedicated to providing lasting solutions to health crises, with the mission of helping people to help themselves. Identifiable to many by the SS HOPE, the world’s first peacetime hospital ship, Project HOPE now conducts land-based medical training and health education programs in 35 countries across five continents.
Media contact: Geraldine Carroll Tel. 540.257.3746 email@example.com
Geraldine Carroll Tel. 540.257.3746 firstname.lastname@example.org
Get news from the field and updates on how your donations are being put to work.
Read and share stories about Project HOPE with your personal network.